ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Lung Cancer
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Low-Dose CT Screening for Lung Cancer Linked to Lower Risk of Brain Metastasis
Patients who underwent CT screening had a lower risk of brain metastasis than patients whose cancer was detected via other methods.
Prognostic Understanding Influences Patients’ Lung Cancer Care Decisions at the End of Life
Researchers assessed the associations between patients’ understanding of their prognosis and their end-of-life care decisions.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Preoperative LAMA/LABA Reduces Surgical Complications in Lung Cancer With COPD
Preoperative use of a LAMA with a LABA was associated with significant improvements in lung function compared with use of LAMA alone in patients with lung cancer and COPD.
Lumakras Gets Accelerated Approval for KRAS G12C-Mutated NSCLC
The Food and Drug Administration (FDA) has granted accelerated approval to Lumakras (sotorasib) for the treatment of adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least 1 prior systemic therapy. Sotorasib, an inhibitor of the RAS GTPase family, works by…
Rybrevant Approved for NSCLC With EGFR Exon 20 Insertion Mutations
The approval was based on data from the phase 1 CHRYSALIS trial that evaluated Rybrevant in 81 patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations whose disease had progressed on or after platinum-based chemotherapy.
USPSTF Releases Updated Lung Cancer Screening Guidelines
An overview of the impact the updated USPSTF Lung Cancer Screening Guidelines will have on diagnosis and survival of lung cancer.
COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...